.widget.ContactForm { display: none; }

Wednesday, December 29, 2021

Spider-Man: No Way Home Becomes Highest-Grossing Film in Sony Pictures’ History

Days after becoming the first film of the pandemic era to cross the $1 billion mark at the box office, Spider-Man: No Way Home has broken yet another record, becoming the highest-grossing film in Sony Pictures’ history.

Said record was previously held by 2019’s Spider-Man: Far From Home, which grossed $1.13B worldwide. Currently, No Way Home‘s global cume stands at $1.16M, split across $516.4 domestic and $644.9 internationally. The film’s top international markets, as of Tuesday the 28th, were the United Kingdom ($76.6M), Mexico ($57.9M), South Korea ($43.2M), France ($42.1M), and Australia ($35.9M). Notably absent from the list is China, where Spider-Man: No Way Home has not yet been released, making the film’s record-breaking haul all the more impressive. (Far From Home did screen in China, to the tune of $198.9M over its run.)

Further potentially limiting factors in No Way Home‘s release was a new series of Covid-imposed shutdowns and restrictions affecting certain international markets during the film’s opening two weekends; these include Quebec (where theaters were subject to limited capacity, then ordered to close days later) and British Columbia (50% capacity) in Canada, as well as curfews in South Korea and cinema closures in the Netherlands, Denmark, and Belgium—though Belgium has since re-opened their cinemas.

Top International market cumes through Tuesday, December 28

United Kingdom $76.6 million
Mexico $57.9 million
South Korea $43.2 million
France $42.1 million
Australia $35.9 million
Brazil $35.6 million
India $30.9 million
Russia $30.1 million
Germany $23.2 million
Italy $21.0 million
Spain $18.5 million
Hong Kong $14.1 million
Taiwan $13.2 million
Argentina $12.0 million
Malaysia $10.8 million

The post <em>Spider-Man: No Way Home</eM> Becomes Highest-Grossing Film in Sony Pictures’ History appeared first on Boxoffice.



from Boxoffice

0 comments:

Post a Comment